Last checked at 5 Dec 2013 15:52
5 December 2013
CVS Group plc
("CVS" or the "Company")
Exercise of Share Options
CVS, the UK's leading provider of veterinary services, announces that it today received notification that on 5 December 2013, Simon Innes, Chief Executive Officer of the Company, together with certain other senior employees of the Company, exercised options at 0.2 pence per share over an aggregate 500,944 ordinary shares of 0.2 pence each in the Company ("New Shares"), under the CVS Group Long Term Incentive Plan 2010/2013. Simon Innes has exercised options over 269,413 ordinary shares.
Application has been made for the New Shares, which rank pari passu in all respects with the Company's existing ordinary shares, to be admitted to trading on AIM which is expected to occur on or about 9 December 2013 ("Admission").
Following Admission of the New Shares, the Company's total issued share capital will consists of 57,698,061 ordinary shares of 0.2p each ("Ordinary Shares") with one voting right per share. The Company does not hold any Ordinary Shares in Treasury. Therefore, following Admission, the total number of voting rights in the Company will be 57,698,061. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
Following Admission, Simon Innes will be interested in 815,888 Ordinary Shares in the Company, representing an interest of 1.41 per cent in the total voting rights of the Company.
Contacts:
CVS Group plc Simon Innes, Chief Executive Nick Perrin, Finance Director
| Tel: 01379 644 288
|
N+1 Singer (Nominated Adviser & Broker) Aubrey Powell Alex Wright
| Tel: 020 7496 3000
|